Evidence map›Paper›PMID 41415078›Full record

ArticleAmerican journal of translational research2025

Epithelioid hemangioma in the male breast: a rare case report and review of the literature.

Shu-Xin Xu, Xi-Hao Ni, Chang-Liang Wang, Hong-Wei Zheng

Abstract read
In one paragraph

Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shu-Xin XuSchool of Nursing, Shandong Second Medical University Weifang 261041, Shandong, The People's Republic of China.
Xi-Hao NiSchool of Clinical Medicine, Shandong Second Medical University Weifang 261041, Shandong, The People's Republic of China.
Chang-Liang WangThyroid and Breast Diagnosis and Treatment Center, The First Affiliated Hospital of Shandong Second Medical University Weifang 261041, Shandong, The People's Republic of China.
Hong-Wei ZhengAnesthesiology Department, Weifang People's Hospital Weifang 261041, Shandong, The People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesEpithelioid Hemangioma (EH), also known as Angioblastic Lymphoid Hyperplasia with Eosinophilia (ALHE), is a rare benign vascular proliferative disease.

methodsA 61-year-old male presented with a mass in the upper outer quadrant of the right breast, and ultrasound suggested a BI-RADS category 4c lesion in the right breast. Pathological examination revealed vascular proliferation with endothelial proliferation on a background of collagenized fibrosis, with some endothelial cells showing epithelioid changes and protruding into the vascular lumen, accompanied by lymphocytes and a few eosinophilic granulocytes in the stroma.

resultsThe diagnosis of epithelioid hemangioma was made based on immunohistochemistry.

conclusionWe briefly analyzed the pathogenesis, imaging manifestations, histopathology, and treatment methods of epithelioid hemangioma.

Indexed as

case reportdiagnosis and treatmentepithelioid hemangiomaMale breast tumor

Identifiers

PMID41415078
PMCPMC12709330

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.